:: Altroz - News Magazine HTML Template ::

Language:

obesity News

Eli Lilly Aims to Revolutionize India's Pharmaceutical Market with Innovative Diabetes and Obesity Treatments

Olivia Carter 26 Mar, 2025

Eli Lilly plans to transform India's pharmaceutical market with innovative treatments for diabetes and obesity, leveraging AI and global expertise to address the country's health c...

Business

Novo Nordisk Faces Significant Stock Drop Following Obesity Drug Trial Disappointment

Emily Rodriguez 20 Dec, 2024

Novo Nordisk's stock dropped 18% after a phase three trial for its CagriSema weight loss drug yielded results below expectations. The drug, combining semaglutide and Cagrilintide, ...

obesity News

Eli Lilly Aims to Revolutionize India's Pharmaceutical Market with Innovative Diabetes and Obesity Treatments

Novo Nordisk Faces Significant Stock Drop Following Obesity Drug Trial Disappointment

Popular News

The Turbulent C-Suite Shuffle in India's IT Sector: A Closer Look

Wall Street Dips as Investors React to Trump's New Metal Tariffs and Await Earnings Reports

European Markets Tumble: DAX Leads with a 2% Drop Amid Tariff Tensions and Inflation Fears

European Markets Rally Dramatically: DAX and EURO STOXX Surge Over 8% Amid Easing Trade Tensions

Apple Nears $4 Trillion Market Cap on AI-Driven Growth

Dollar Makes Marginal Gains Against Vietnamese Dong Amid Global Market Fluctuations

Kraken Crypto Exchange Fined $5.1 Million by Australian Regulators

Union Budget 2025: A Boost for Middle-Class Spending and Economic Growth

Newsletter

Subscribe Newsletter!

Privacy Policy

Terms & Conditions

Contact Us